The Safety and Efficacy of Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Combination With C-CAR088, an Autologous BCMA CAR-T Cell Product, for Treating Patients With Ultra High-risk Multiple Myeloma
Latest Information Update: 18 Feb 2024
At a glance
- Drugs C CAR088 (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
Most Recent Events
- 05 Dec 2022 New trial record